|

Adebrelimab，Fruquintinib Clinical Trials

2 actively recruiting trials

Top Sponsors

  • Tianjin Medical University Cancer Institute and Hospital2

Indications

  • Gastric Cancer2
  • Cancer2

Other2 trials

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.